Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dominant transplantation tolerance. Opinion.

Luis Graca1, Alain Le Moine, Stephen P Cobbold

  • 1Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK. luis.graca@pathology.oxford.ac.uk

Current Opinion in Immunology
|September 23, 2003
PubMed
Summary

Short antibody treatments can induce long-term allograft survival by promoting regulatory T cells. The exact nature and function of these CD4+ regulatory T cells remain under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysregulation of helper, regulatory, and follicular CD4<sup>+</sup> T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy.

Autoimmunity reviews·2026
Same author

Cell motility influences microfluidics capturing in scRNA-seq.

Open research Europe·2026
Same author

A Partial <i>UMOD</i> Deletion Results in Altered Uromodulin Synthesis and Autosomal-Dominant Tubulointerstitial Kidney Disease-Uromodulin.

Kidney medicine·2026
Same author

Comment on: Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome: reply.

Rheumatology (Oxford, England)·2026
Same author

A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritis.

Immunotherapy advances·2025
Same author

Assessing the Accuracy of the International Evidence-Based Kyoto Guidelines for Detecting Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.

GE Portuguese journal of gastroenterology·2025

Area of Science:

  • Immunology
  • Transplantation immunology

Background:

  • Long-term survival of transplanted organs (allografts) typically requires continuous immunosuppression.
  • Nondepleting antibodies targeting molecules like CD4 or CD154 (CD40 ligand) offer a potential alternative to induce tolerance.

Purpose of the Study:

  • To investigate the mechanisms underlying long-term allograft survival induced by short-term antibody treatment.
  • To explore the role of CD4+ regulatory T cells in maintaining graft tolerance.

Main Methods:

  • Treatment of recipients with nondepleting antibodies (anti-CD4 or anti-CD154).
  • Analysis of immune cell populations within lymphoid tissues and the allograft.
  • Characterization of regulatory T cell phenotype and function.

Related Experiment Videos

Main Results:

  • Short-term antibody therapy can lead to sustained allograft survival without ongoing immunosuppression.
  • This tolerance appears to be mediated by regulatory T cells (Tregs).
  • The precise phenotype and function of these Tregs, and their relationship to CD4+CD25+ T cells, are not fully elucidated.

Conclusions:

  • Nondepleting antibody therapy is a promising strategy for inducing stable allograft tolerance.
  • CD4+ regulatory T cells are key players in this tolerance mechanism.
  • Further research is needed to clarify the specific characteristics and actions of these regulatory T cells.